Ó£»¨ÊÓƵ

Skip to main content

Table 3 Enrolment in each centre according to target groups and primary cancer diagnosis

From: Validation of the European Oncology toolkit for the self-assessment of Quality of Life (EUonQoL-Kit) in cancer patients and survivors: study protocol of a pan European survey

Primary cancer diagnosis

Group A

Active treatment

Group B

Survivors

Group C

Palliative care

Total

Lung cancer

6 ±â¶Ä‰1

5 ±â¶Ä‰1

5 ±â¶Ä‰1

16 ±â¶Ä‰2

Breast cancer

6 ±â¶Ä‰1

5 ±â¶Ä‰1

5 ±â¶Ä‰1

16 ±â¶Ä‰2

Colorectal cancer

6 ±â¶Ä‰1

4 ±â¶Ä‰1

4 ±â¶Ä‰1

14 ±â¶Ä‰2

Haematological malignancies*

6 ±â¶Ä‰1

4 ±â¶Ä‰1

4 ±â¶Ä‰1

14 ±â¶Ä‰2

Prostate cancer

6 ±â¶Ä‰1

4 ±â¶Ä‰1

4 ±â¶Ä‰1

14 ±â¶Ä‰2

Other cancer

10 ±â¶Ä‰2

8 ±â¶Ä‰2

8 ±â¶Ä‰2

26 ±â¶Ä‰2

Total

40

30

30

100

  1. *Haematological malignancies include lymphomas